Increased risk of myocardial infarction with dabigatran etexilate: fact or fiction? A critical meta-analysis of over 580,000 patients from integrating randomized controlled trials and real-world studies-Reference-Cited by-同舟云学术

Increased risk of myocardial infarction with dabigatran etexilate: fact or fiction? A critical meta-analysis of over 580,000 patients from integrating randomized controlled trials and real-world studies

Published:2018-09 Issue: Volume:267 Page:1-7
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Wei An-Hua,Gu Zhi-Chun,Zhang Chi,Ding Yu-Feng,Liu Dong,Li Juan,Liu Xiao-Yan,Lin Hou-Wen,Pu Jun

Funder

Shanghai Jiaotong University School of Medicine

Program for Key Discipline of Clinical Pharmacy of Shanghai

Program for Key but Weak Discipline of Shanghai Municipal Commission of Health and Family Planning

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference47 articles.

1. Increased risk of myocardial infarction with dabigatran: fact or fiction?;Giglio;J Cardiovasc Med (Hagerstown),2014

2. Dabigatran in real-world atrial fibrillation. Meta-analysis of observational comparison studies with vitamin K antagonists;Carmo;Thromb. Haemost.,2016

3. Coronary and mortality risk of novel oral antithrombotic agents: a meta-analysis of large randomised trials;Mak;BMJ Open,2012

4. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N. Engl. J. Med.,2009

5. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter;Cairns;Can J Cardiol,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation: A network meta-analysis;Journal of the Formosan Medical Association;2023-11

2. Effectiveness and safety of extended thromboprophylaxis in post-discharge patients with COVID-19: A systematic review and meta-analysis;Thrombosis Research;2023-01

3. The Use of Oral Anticoagulation Is Not Associated With a Reduced Risk of Mortality in Patients With COVID-19: A Systematic Review and Meta-Analysis of Cohort Studies;Frontiers in Pharmacology;2022-03-31

4. Do non-vitamin K antagonist oral anticoagulants increase the risk of myocardial infarction?;Kardiologia Polska;2022-01-31

5. New Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Total Hip and Knee Arthroplasty: A Systematic Review and Network Meta-Analysis;Frontiers in Pharmacology;2022-01-17